Memery Crystal acts for Biofrontera regarding Biopharma AIM listings

Memery Crystal has acted for Biofrontera, whose shares have now been admitted to trading on AIM.

Biofrontera is a German company and is listed on the Frankfurt Stock Exchange.

The Memery Crystal team was led by corporate partner Lesley Gregory, and included corporate associate Caitlin Malloy and solicitor Vickie Miller.

According to the firm, Biofrontera’s admission to AIM should raise its international profile in the life sciences arena and provide access to capital should further finance be required to expand the business in the future.